“There is no change to the full-year guidance; it's the same as before.”

In context

“Roei Golan (CFO): I'll start with the last point. There is no change to the full-year guidance; it's the same as before. Regarding the inorganic contribution, we completed the Perimeter 81 acquisition, which added about $7 million in revenue. This translates to roughly $7 million in billings, approximately 1.1 something. As for your question about the necessary investments, I don't want to disclose specific numbers. However, we have heavily invested in the past few years in both our go-to-market strategies and in our product development to enhance our portfolio significantly compared to what we had a few years ago. While we have seen a decline in our margins, I believe these investments will lead to growth. We are not stopping our investments; in fact, we plan to continue investing. With the improved portfolio we have today, we aim to achieve double-digit growth, which will also positively impact billings and cash flow. I believe all your questions are connected to this. I don’t want to commit to a specific margin, but we currently have a solid operating margin, and I am hopeful that it will improve in the mid to long term. Ultimately, our success depends on our execution, and I am optimistic that we can achieve higher growth and enhance our operating margin.”